Compound X an inhaled β<sub>2</sub> agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction - Berlin 2008

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Berlin 2008

Novel treatments for respiratory disease

Chair(s): C. Page (London, United Kingdom), M. Cazzola (Rome, Italy)

Session type: Oral Presentation

Compound X an inhaled β₂ agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction

K. Wright, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)

EVENTS HOME

Limited Access

Please log in to myERS to view this content.

Don't have a myERS account? Register

Note: consult the ERS Respiratory Channel access rights page for more details.

CDN Connection Issue

The ERS International Congress 2008, Berlin

Limited Access

#{title}